rmp, you appear to be revealing your negative bias. The poor logic of your comment does not stand up to scrutiny. Why on earth would the company attempt to raise capital before the results of highly price sensitive trials are in hand?
The compamy has sufficient funds to do what it says it needs to do. What happens after that, I suggest, will depend entirely on how good those results are.
management disappoints again, page-5
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
